Overview
Peachtree BioResearch Solutions is a full-service CRO that plans and runs clinical trials for mid-sized pharmaceutical, biotech, and medical device sponsors. It offers feasibility, site recruitment, clinical site management and monitoring, data management, biostatistics, medical monitoring, medical writing, and quality assurance, supported by a team of experienced professionals and systems like IBM Clinical for EDC, Veeva Vault for eTMF, ZenQMS, and Oracle CTMS to keep trials on track. The company differentiates itself with a focus on seasoned personnel and hands-on collaboration to help sponsors with limited resources by providing flexible, reliable, and issue-solving support. Its goal is to understand sponsor challenges and deliver practical solutions that keep clinical programs on schedule and aligned with study goals.
Work here?Claim your company
Simplify's take
What believers are saying
- May 2025 merger expands reach across Europe and North America immediately.
- P95 integration adds infectious disease and vaccine capabilities beyond Peachtree's CNS core.
- Company still markets active services in 2026, signaling ongoing commercial demand.
What critics are saying
- Integration after May 2025 merger risks client churn and execution slippage through 2026.
- Ampersand-backed Julius Clinical can rationalize overlapping teams, reducing Marietta roles.
- A failed post-merger platform threatens Peachtree's independence inside P95 Julius Clinical.
What makes Peachtree BioResearch Solutions unique
- May 2025 merger with Julius Clinical created a larger global CRO.
- Peachtree brings CNS expertise from Georgia into Europe-North America operations.
- Founded 2008, it serves emerging biotech, pharma, and device companies.
Help us improve and share your feedback! Did you find this helpful?